NON RARE IN EUROPE: Idiopathic facial palsy

Idiopathic facial palsy, commonly known as Bell's palsy, is a condition characterized by sudden, unilateral weakness or paralysis of the facial muscles due to dysfunction of the seventh cranial nerve (facial nerve). The cause is considered idiopathic, meaning it arises without a clearly identifiable cause, although viral reactivation (particularly herpes simplex virus type 1) is widely suspected as a contributing factor. The condition primarily affects the peripheral nervous system and the muscles of facial expression. It is classified as non-rare in Europe due to its relatively high incidence. Key symptoms include sudden onset of one-sided facial weakness or complete paralysis, inability to close the eye on the affected side, drooping of the mouth corner, loss of the nasolabial fold, difficulty with eating and drinking, altered taste sensation on the anterior two-thirds of the tongue, hyperacusis (increased sensitivity to sound on the affected side), and decreased tearing or excessive tearing of the affected eye. Patients may also experience pain behind or in front of the ear on the affected side preceding or accompanying the onset of weakness. The prognosis is generally favorable, with the majority of patients (approximately 70-85%) recovering completely within weeks to months without treatment. Current treatment typically includes a short course of oral corticosteroids (such as prednisolone), ideally initiated within 72 hours of symptom onset, which has been shown to improve recovery rates. Eye protection measures, including artificial tears, lubricating ointments, and eye patching, are essential to prevent corneal damage due to incomplete eyelid closure. The role of antiviral medications remains debated, though they are sometimes prescribed in combination with corticosteroids, particularly in severe cases. Physical therapy and facial rehabilitation exercises may also be recommended. A small proportion of patients may experience incomplete recovery, with residual facial weakness, synkinesis (involuntary facial movements), or contracture.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about NON RARE IN EUROPE: Idiopathic facial palsy